Physician

Anwar Mack, MD

According to 2025 Medicare claims, Anwar Mack, MD (NPI: 1184010597) practices pain management in the Reno, NV market, with the plurality of this provider's patient population coming from Washoe, NV. This provider's primary affiliated billing organization is BERMAN & MACK LTD. (NPI: 1942310990; TIN: 20-5244843) and primary practice location at 89511-2093.

Mack's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 964 traditional Medicare patients, billed 36,485 HCPCS/CPT codes, and received $573,115 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 801 prescription claims across 231 beneficiaries totaling $24,557 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). Open Payments data shows 99 records totaling $5,590. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $111,266 to $573,115. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,044 and ending at $24,557. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$343K$686K2020 Medicare payment: $111,266 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $253,419 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $518,657 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $686,147 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $573,115 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20202531,441$111,266
20214244,483$253,419
202285714,044$518,657
202398325,360$686,147
202496436,485$573,115

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$119K$238K2015 Drug cost: $1,044 (USD; Tot_Drug_Cst)2016 Drug cost: $8,931 (USD; Tot_Drug_Cst)2019 Drug cost: $299 (USD; Tot_Drug_Cst)2020 Drug cost: $73,945 (USD; Tot_Drug_Cst)2021 Drug cost: $152,884 (USD; Tot_Drug_Cst)2022 Drug cost: $237,716 (USD; Tot_Drug_Cst)2023 Drug cost: $56,347 (USD; Tot_Drug_Cst)2024 Drug cost: $24,557 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151221$1,044
20161640$8,931
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R13$299
20201681,010$73,945
20213412,908$152,884
20226675,051$237,716
20233821,484$56,347
2024231801$24,557

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7482,489$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more430742$66
80307Testing for presence of drug, by chemistry analyzers417579$60
96127Assessment of emotional or behavioral problems5731,347$3
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg169852$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1433,783$3,243
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl21622$2,710
PregabalinPregabalin461,558$1,809
Oxycodone HclOxycodone Hcl942,032$1,317
Duloxetine HclDuloxetine Hcl331,410$1,028

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.99$5,590Medtronic, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anwar Mack, MD?

Tedicare shows public-source Medicare data for Anwar Mack, MD (NPI 1184010597), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anwar Mack, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anwar Mack, MD?

Anwar Mack, MD is linked to BERMAN & MACK LTD. (billing NPI 1942310990) in the available physician profile data.

Does Anwar Mack, MD have Open Payments data?

Anwar Mack, MD has 99 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.